Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Intrust Bank NA

Intrust Bank NA trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 7,429 shares of the medical equipment provider’s stock after selling 49 shares during the period. Intrust Bank NA’s holdings in Intuitive Surgical were worth $3,878,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Allstate Corp acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $5,476,000. Brown Brothers Harriman & Co. raised its position in Intuitive Surgical by 26.9% during the 4th quarter. Brown Brothers Harriman & Co. now owns 3,373 shares of the medical equipment provider’s stock worth $1,761,000 after buying an additional 714 shares during the last quarter. DnB Asset Management AS lifted its stake in Intuitive Surgical by 8.0% during the 4th quarter. DnB Asset Management AS now owns 100,531 shares of the medical equipment provider’s stock valued at $52,473,000 after acquiring an additional 7,406 shares during the period. Alerus Financial NA boosted its holdings in shares of Intuitive Surgical by 177.1% in the 4th quarter. Alerus Financial NA now owns 9,678 shares of the medical equipment provider’s stock valued at $5,052,000 after acquiring an additional 6,186 shares during the last quarter. Finally, Level Four Advisory Services LLC increased its stake in shares of Intuitive Surgical by 18.3% in the fourth quarter. Level Four Advisory Services LLC now owns 894 shares of the medical equipment provider’s stock worth $467,000 after acquiring an additional 138 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on ISRG. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. UBS Group raised their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Wells Fargo & Company upped their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Stock Down 3.2 %

Intuitive Surgical stock opened at $491.84 on Friday. The company has a fifty day simple moving average of $556.28 and a 200-day simple moving average of $532.34. The firm has a market capitalization of $175.18 billion, a price-to-earnings ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.